Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors
Schematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG Dangge

Immune checkpoint blockade (ICB) therapy using the antibody that combats the programmed cell death ligand 1 (PD-L1) shows great potential and is causing a revolution in clinical cancer management. Unfortunately, only a subset of treated patients responds to current ICB therapies, likely due to the immunological tolerance of tumors. Therefore, developing a practical strategy to combat this immunological tolerance and amplify ICB therapies has become a priority.

To meet this challenge, scientists from the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences have developed a enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy. This research was published online in Science Immunology.

In this study, Prof. Yu Haijun, Prof. Li Yaping and their colleagues engineered the antibody nanoparticles by integrating anti-PD-L1 antibody (αPDL1) and indocyanine green (ICG) into a single nanoplatform. ICG is a clinically approved fluorophore for fluorescence imaging in live surgery, and a photosensitizer for photodynamic therapy (PDT). The antibody nanoparticles remain inert in blood circulation and protect αPDL1 from binding with normal tissues. Once accumulated at the tumor site through the enhanced permeability and retention (EPR) effect, the antibody nanoparticles become activated to release αPDL1 for tumor-specific PD-L1 blockading.

Moreover, the scientists revealed that the antibody nanoparticles triggered the release of tumor antigens and promoted intratumoral infiltration of cytotoxic T lymphocytes (CTLs) through the ICG-based PDT effect. "This is crucial for cancer immunotherapy since CTLs have been well-identified as the killer of tumor cells," explained Prof. Yu, co-corresponding author of the study.

Elegant antibody nanoparticles override immunological tolerance of tumors
Illustration of activated nanoparticles carrying PD-L1 antibody (blue) and photosensitizer (green). Credit: Wang et al., Sci. Immunol. 4, eaau6584 (2019)

Finally, they showed that the antibody not only boost antitumor immunity with great efficiency, but also elicit long-term immune memory effects in BALB/c mice, thus leading to remarkable tumor regression.

In particular, the antibody nanoparticle-mediated combination of ICB and PDT effectively suppressed and metastasis to the lung and when using a 4T1 tumor-bearing BALB/C mouse model, which resulted in survival for >70% of the mice for more than 65 days, compared to complete mouse death in 42 days for the free αPDL1 group.

Elegant antibody nanoparticles override immunological tolerance of tumors
Distribution of nanoparticles carrying PD-L1 antibody (blue) and photosensitizer (red) in a mouse’s lymph nodes four hours post injection. The nanoparticles were highly efficient in accumulating at all the draining lymph nodes and distributed throughout the sections of tumoral metastatic regions. Credit: Wang et al., Sci. Immunol. 4, eaau6584 (2019)

"We provided a robust antibody nanoplatform for priming the antitumor immunity and inhibiting the immune checkpoint, which could be readily adapted to other immune checkpoint inhibitors for enhanced ICB therapies. Given the simplicity of the nanostructures, our study has the potential of being translated into future generations of cancer immunotherapy," Prof. Yu said.


Explore further

Combination immunotherapy targets cancer resistance

More information: D. Wang el al., "Engineering nanoparticles to locally activate T cells in the tumor microenvironment," Science Immunology (2019). immunology.sciencemag.org/look … 6/sciimmunol.aau6584
Journal information: Science Immunology

Citation: Elegant antibody nanoparticles override immunological tolerance of tumors (2019, July 12) retrieved 16 July 2019 from https://medicalxpress.com/news/2019-07-elegant-antibody-nanoparticles-override-immunological.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
124 shares

Feedback to editors

User comments

Jul 13, 2019

God bless Dr Takuta for your wonderful help i love you so much Dr Takuta I we always tell people about You I Love You for your wonderful herbs medicine that got me free from my hiv and herpes illness God bless you Doctor Takuta I Love You So Much (takutaspellalter@gmail.com)or WhatsApp him on this Tell.Number +27788634102.. Beware of scams Love You Dr Takuta

Dr.TAKUTA also cures:
1. HEPATITIS A,B,C
2. HERPES 1/2
3.DIABETES
4.STROKE.
5.STDS and STI
6. MARRIAGE COUNSELLING
7.LOVE SPELL CASTING
8.JOB PROMOTION SPELLS
9.MARITAL PROBLEM
10.MAGIC MONEY SPELLS

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more